Completed and Published Trials

The clinical trials listed below have closed for recruitment, with the results published in medical journals, or manuscript preparation underway. Please click on the links below for further information about completed and published trials currently, including links to publications.

01.02 Adj RT
01.06 MSLT-I
02.06 MSLT-II
01.07 SS 01.13 Hair Spare
01.09 MelQOL Research Study
02.09 Mel-D
01.13 Psycho-educational intervention
02.14 CombiRT
02.17 MEL-SELF (pilot)
03.17 Skin Cancer Prevention
06.17 iMOVE
04.18 Surgical Management Survey

01.02 Adj RT

A randomised clinical trial of surgery versus surgery plus adjuvant radiotherapy of regional control in patients with completely resected nodal metastatic melanoma

Chair

Professor Michael Henderson and Professor Bryan Burmeister

Registration ID

ACTRN1260700003415

Trial Status

Completed and Published Trial

Main publication

https://www.ncbi.nlm.nih.gov/pubmed/22575589

MASC Trials Contact

hello@masc.org.au

01.06 MSLT-I

Multicentre selective lymphadenectomy trial - I

Chair

Professor John Thompson

Registration ID

NCT00275496

Trial Status

Completed and Published Trial

Main publication

https://www.nejm.org/doi/full/10.1056/nejmoa1310460

MASC Trials Contact

hello@masc.org.au

02.06 MSLT-II

Multicentre selective lymphadenectomy trial - II

Chair

Professor John Thompson

Registration ID

NCT00297895

Trial Status

Completed and Published Trial

Main publication

https://www.nejm.org/doi/full/10.1056/NEJMoa1613210

MASC Trials Contact

hello@masc.org.au

01.07 SS 01.13 Hair Spare

A feasibility study of hair sparing whole brain radiotherapy with volumetric modulated arc therapy for patients who have brain metastases from any malignancy

Chair

Professor Gerald Fogarty

Registration ID

ACTRN12617000507381

Trial Status

Completed and Published Trial

Main publication

https://medcraveonline.com/IJRRT/IJRRT-07-00274.pdf

MASC Trials Contact

hello@masc.org.au

01.09 MelQOL Research Study

Improving Quality of Life (QOL) measurement for melanoma patients and their families: Validity and reliability study of QOL instruments in an Australian sample

Chair

Julie Winstanley

Registration ID

ACTRN12609000344291

Trial Status

Completed and Published Trial

Main publication

https://pubmed.ncbi.nlm.nih.gov/25325247/

MASC Trials Contact

hello@masc.org.au

02.09 Mel-D

Vitamin D following primary treatment of melanoma at high risk of recurrence - a pilot placebo controlled randomised Phase II trial

Chair

Associate Professor Robyn Saw

Registration ID

ACTRN12609000351213

Trial Status

Completed and Published Trial

Main publication

In preparation

MASC Trials Contact

hello@masc.org.au

01.13 Psycho-educational intervention

A randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary disease

Chair

Associate Professor Anne Cust and Dr Mbathio Dieng

Registration ID

ACTRN12613000304730

Trial Status

Completed and Published Trial

Main publication

http://ascopubs.org/doi/full/10.1200/JCO.2016.68.2278

MASC Trials Contact

hello@masc.org.au

02.14 CombiRT

An open-label, single-arm, Phase I/II, multicentre study to evaluate the safety and efficacy of the combination of dabrafenib, trametinib and palliative radiotherapy in patients with unresectable (stage IIIc) and metastatic (stage IV) BRAF V600E/k mutation-positive cutaneous melanoma

Chair

Dr Tim Wang

Registration ID

ACTRN12615000292572

Trial Status

Completed and Published Trial

Main publication

In progress

MASC Trials Contact

hello@masc.org.au

02.17 MEL-SELF (pilot)

Pilot trial: Can patient-led surveillance detect more early stage recurrent or new primary melanoma than clinician-led surveillance?

Chair

Dr Katy Bell

Registration ID

ACTRN12616001716459

Trial Status

Completed and Published Trial

Main publication

In progress

MASC Trials Contact

hello@masc.org.au

03.17 Skin Cancer Prevention

Improving skin cancer prevention: Motivating preventative behaviours using knowledge of personalised genomic risk of melanoma

Chair

Associate Professor Anne Cust

Registration ID

ACTRN12617000691347

Trial Status

Completed and Published Trial

Main publication

https://www.sciencedirect.com/science/article/abs/pii/S1877782119300360?via%3Dihub

MASC Trials Contact

hello@masc.org.au

06.17 iMOVE

A personalised, semi-supervised exercise intervention to reduce fatigue for patients receiving immunotherapy for stage IV melanoma – a pilot study

Chair

Dr Donna Milne

Registration ID

ACTRN12619000952145

Trial Status

Completed and Published Trial

Main publication

Analyses completed, publication in progress

MASC Trials Contact

hello@masc.org.au

04.18 Surgical Management Survey

Current practice for the management of patients with stage III melanoma: an international survey

Chair

Dr David Gyorki

Registration ID

N/A

Trial Status

Completed and Published Trial

Main publication

In preparation

MASC Trials Contact

hello@masc.org.au